EASTMAN CHEMICAL CO

Eastman Chemical's capital structure shows a debt-to-equity ratio of 0.8, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.37, suggesting it can cover its short-term obligations, though net cash is negative after subtracting total debt. Free cash flow of $424 million in FY2025 supports operational flexibility and potential for shareholder returns. Profitability metrics show a return on equity of 7.95% and a return on assets of 3.19%, both below the industry median for specialty chemicals. Gross profit of $1.84 billion and net income of $474 million reflect a gross margin of 21.07% and a net margin of 5.42%, which are in line with the sector but suggest room for improvement in cost control and pricing power. Geographically, Eastman's revenue is concentrated in the United States and Canada (33%) and Asia Pacific (36%), with Europe, Middle East, and Africa accounting for 25%. Segment-wise, the Advanced Materials segment contributes 32% of total sales, followed by Additives & Functional Products at 38%. The Chemical Intermediates segment accounts for 76% of its sales, indicating a high dependency on this business line. Growth trajectory is mixed. FY2025 revenue of $8.75 billion shows a 4.7% decline from FY2024's $9.36 billion. Adjusted EBIT for FY2025 was $1.11 billion, down from $1.51 billion in FY2024. The outlook for FY2026 suggests a modest recovery, with projected revenue growth of 2.3% and EBIT expansion of 1.8%. Risk factors include a medium liquidity risk due to negative net cash and a debt-to-equity ratio above the sector median. Dilution risk is low, with a dilution potential basic of 51.1% and no recent equity issuance. However, the company's exposure to geopolitical drivers such as trade tariffs and energy costs remains a concern. Recent events include Q3 2025 results showing a 6.3% decline in sales to $2.197 billion compared to Q3 2024. Adjusted EBIT for the quarter was $249 million, down from $407 million in the prior year. The company also disclosed restructuring activities and asset impairments in its 10-K filing, which impacted EBIT.